What happened
Yungjin Pharm updated a previously disclosed supply contract with MYLAN SEIYAKU LTD, now worth US$9.15M, about 5.5% of its recent annual revenue, running through Oct 2027.
For context, this single contract equals about 5.5% of the company's most recent annual revenue.
| Counterparty | MYLAN SEIYAKU LTD |
|---|---|
| Contract value | US$9.15M |
| vs. recent revenue | 5.5% |
| Through | Oct 2027 (from Oct 2020) |
| Filed | 2026-10-08, [Amended] Supply contract signed |
| Source | DART rcept 20261008800579 → open original filing |
Source: DART. Information only, not investment advice.